EpiMonitor is now available in Europe

Following its successful US launch and FDA clearance, Empatica is proud to announce that EpiMonitor, its pioneering epilepsy monitoring solution, is now a CE-certified device according to EU Medical Device Regulation 2017/745 and available in Europe. EpiMonitor is a game-changing, medical-grade wearable and app combination that revolutionizes epilepsy care, providing seizure detection and alerting alongside continuous health monitoring capabilities also used in clinical research settings.

EpiMonitor comprises the sophisticated EmbracePlus watch and a companion smartphone app. EpiMonitor’s algorithm continuously analyzes user data, looking for patterns that may resemble a generalized tonic-clonic seizure, and sends automated alerts to caregivers with scientifically proven 98% accuracy. EpiMonitor also offers a detailed sleep, activity, and seizure diary, providing people with epilepsy and their doctors with important information to make empowered decisions on their health journey.

Which EU countries is EpiMonitor available in?

EpiMonitor can now be purchased in Germany, France, Italy, Spain, Denmark, Sweden, Belgium, Luxembourg, Austria, Liechtenstein, Ireland, the Netherlands, Malta, and Finland. The EpiMonitor app is also available in all local languages for a seamless experience for its users.

Key features of EpiMonitor

• Fully medical-grade technology consisting of a wearable and app
• Automatic generalized tonic-clonic seizure detection and alerts to caregivers (98% accuracy; low False Alarm Rate)
• Ability for users to send self-triggered alerts to caregivers
• Up to 7 days of battery life
• A user-friendly mobile app with a detailed, automated diary
• Daily sleep and activity tracking through Empatica’s algorithms
• Detailed reports that can be exported and shared with a doctor
• High accessibility with app translations in 8 languages
• Compatibility with iOS and Android smartphones

Empatica has been the market leader in providing the world’s only medical watches for people living with epilepsy for nearly a decade. Epilepsy affects 6 million people in Europe, with approximately 15% of those being children. Studies indicate that up to 40% of epilepsy cases are difficult to treat, and a third of people with epilepsy are refractory to current medications. Sudden Unexpected Death in Epilepsy (SUDEP) is the number one cause of epilepsy-related deaths in people with pharmacoresistant epilepsy. Most SUDEP deaths occur when a generalized tonic-clonic seizure occurs during sleep.

EpiMonitor can be purchased directly from our online store.

Visit empatica.com/epimonitor and start your journey towards more peace of mind today.

Own an Embrace2?

EpiMonitor is the successor to Embrace2, the world’s leading wearable for seizure detection for years. As of today, Embrace2 will no longer be available for purchase, but if you are an Embrace2 user worry not — all its services will continue to function normally, providing you with peace of mind with its accurate alerts.

Embrace users in Europe can also take advantage of our trade-in program, and exchange their Embrace with EpiMonitor with a few simple steps and a small fee.